title: Using patient DNA to optimize therapy in heart failure patients: a move toward perfection.
authors: UNC Institute for Pharmacogenomics and Individualized Therapy, Division of Pharmacotherapy and Experimental Therapeutics, and the Lineberger Comprehensive Cancer Center, University of North Carolina, Campus Box 7360, Chapel Hill, NC 27599, USA. hmcleod@unc.edu
authors: Howard L
authors: HL
authors: McLeod
mesh_terms: D002316:Cardiotonic Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D004247:DNA; D055106:Genome-Wide Association Study; D005838:Genotype; D006333:Heart Failure / Q000188:drug therapy* / Q000235:genetics*; D006801:Humans; D007703:Peptidyl-Dipeptidase A / Q000235:genetics; D010597:Pharmacogenetics; D011110:Polymorphism, Genetic; D016896:Treatment Outcome
chemical_list: D002316:Cardiotonic Agents; D004247:DNA; D007703:Peptidyl-Dipeptidase A